SYNCOM FORMULATIONS (INDIA)
|
The Current P/S Ratio of SYNCOM FORMULATIONS (INDIA) is 2.78.
| Share Price | ₹14.5 | Jun 15,2026 |
| Market Cap | ₹1,361.1 Cr | |
| Sales-TTM | ₹489.2 Cr | TTM-Consolidated Results |
| Price/Sales | 2.78x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SYNCOM FORMULATIONS (INDIA)
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,361.1 Cr] as on Jun 15,2026
(/) Sales [ ₹489.2 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.78x ]
Thus, for SYNCOM FORMULATIONS (INDIA) , the investors are currently willing to pay '2.78 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SYNCOM FORMULATIONS (INDIA) !
The chart below summarizes the trend in P/S Ratio of SYNCOM FORMULATIONS (INDIA) over the last five years.
Historical PS (Price/Sales) ratio chart of SYNCOM FORMULATIONS (INDIA)
PS Ratio Performance Analysis for SYNCOM FORMULATIONS (INDIA)
- SYNCOM FORMULATIONS (INDIA) 's p/e ratio for fiscal years ending Mar2025 to Mar2017 averaged 2.96x.
- SYNCOM FORMULATIONS (INDIA) 's operated at median p/e ratio of 3.33x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SYNCOM FORMULATIONS (INDIA) 's p/e ratio peaked in Mar2022 at 4.17x.
- SYNCOM FORMULATIONS (INDIA) 's p/e ratio hit its five-year low in Mar2017 of 0.83x.
How does SYNCOM FORMULATIONS (INDIA) 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SYNCOM FORMULATIONS (INDIA) | 489.2 | 2.78 | 1,361.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.41 | 433,428.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 16.61 | 175,426.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 10.92 | 152,603.0 |
| CIPLA LTD | 28,162.6 | 3.96 | 111,604.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.17 | 106,775.0 |
| MANKIND PHARMA LTD | 14,277.6 | 6.89 | 98,317.8 |
| LUPIN LTD | 27,958.0 | 3.72 | 103,952.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.03 | 109,453.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.41 | 80,955.7 |
| LAURUS LABS LTD | 6,812.9 | 11.02 | 75,056.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SYNCOM FORMULATIONS (INDIA) 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.41x |
| Max industry PS | 16.61x |
| Median industry PS | 4.03x |
| Average industry PS | 6.63x |
You may also like the below Video Courses